This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Improving Asthma Care Through Parental Empowerment (PEPAC)

This study has been completed.
Information provided by (Responsible Party):
Stephen J. Teach, MD, MPH, Children's Research Institute Identifier:
First received: January 29, 2009
Last updated: September 10, 2014
Last verified: September 2014
The overall aim of this study will be to perform a prospective randomized clinical trial of an enhanced version of the IMPACT DC intervention involving short-term case management to facilitate PCP follow-up appointments and to provide education for parents about how to communicate more effectively with their children's PCPs as a means (1) to improve the rate of utilization of primary care services for ongoing asthma care and (2) to enhance the self-efficacy of parents in their interactions with their children's provider regarding the child's asthma care needs in 150 parents of high risk children referred within the IMPACT DC Asthma Clinic.

Condition Intervention
Asthma Behavioral: PEPAC

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Care Provider)
Primary Purpose: Health Services Research
Official Title: Improving Asthma Care Through Parental Empowerment: Effect on Healthcare Utilization and Parent Self-Efficacy

Further study details as provided by Stephen J. Teach, MD, MPH, Children's Research Institute:

Primary Outcome Measures:
  • Utilization of Primary Care Provider [ Time Frame: 2 months & 6 months after visit ]

Secondary Outcome Measures:
  • Parental Self-efficacy in communicating about Asthma care with child's primary care provider [ Time Frame: 2 months & 6 months after visit ]

Enrollment: 150
Study Start Date: January 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Routine IMPACT DC care
Participants receive standard asthma education as routine for IMPACT DC
Experimental: Enhanced care PEPAC Intervention Behavioral: PEPAC
The proposed enhancement of the IMPACT DC intervention will consist of three key components: (1) an enhanced IMPACT DC Asthma Clinic visit; (2) short-term case management to increase the rate of primary care follow-up visits in the first month after the IMPACT DC Asthma Clinic visit; and (3) training in an "asthma care toolkit" to improve communication around asthma care with the child's primary care provider.

Detailed Description:
Asthma is the most common chronic disease of childhood, and it disproportionately affects urban, minority, and disadvantaged children. When implemented correctly, existing evidence-based guidelines from the National Heart, Lung, and Blood Institute (NHLBI) improve pediatric asthma care and outcomes. One key component of these guidelines is the importance of longitudinal care as part of a partnership among patient, parents, and a healthcare provider. Such a partnership depends on effective communication of healthcare status by parents to providers. Improving the communication skills of inner-city parents may improve their ability to obtain more effective longitudinal asthma care within their primary care homes and thereby to improve their child's asthma health outcomes. IMPACT DC ("Improving Pediatric Asthma Care in the District of Columbia") is a locally validated emergency department (ED) based intervention that improves multiple measures of asthma care and outcomes through an intensive short-term program of asthma education, medical care, and care coordination. In spite of these successes, achieving increased subsequent contact and partnership with primary care providers (PCPs) for asthma care after the intervention has not been successful. Therefore, for the current study, we propose to assess the effectiveness of an enhanced version of the existing IMPACT DC intervention consisting of short-term case management by trained asthma educators.

Ages Eligible for Study:   12 Months to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ages between 12 months and 12 years, inclusive
  • prior physician diagnosed asthma
  • ability of the parent to identify a specific PCP for their child
  • public insurance covering the child
  • parent/guardian available for interview

Exclusion Criteria:

  • significant medical co-morbidities
  • enrollment in another asthma research intervention study
  • unavailability for telephone follow-up
  • primary language of the caregiver other than English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00832923

United States, District of Columbia
Children's Research Institute
Washington, District of Columbia, United States, 20010
Sponsors and Collaborators
Children's Research Institute
  More Information

Responsible Party: Stephen J. Teach, MD, MPH, Chief, Division of Allergy and Immunology, Children's Research Institute Identifier: NCT00832923     History of Changes
Other Study ID Numbers: RAC #207
Study First Received: January 29, 2009
Last Updated: September 10, 2014

Keywords provided by Stephen J. Teach, MD, MPH, Children's Research Institute:
parental empowerment
parent self-efficacy

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on July 25, 2017